Vice Provost and Dean of Research
Showing 1,391-1,400 of 1,742 Results
-
Kavita Sarin, MD, PhD
Professor of Dermatology
Current Research and Scholarly InterestsMy research encompasses two main areas: 1) Using next-generation RNA, whole genome, and exome sequencing, we are investigating the genetic alterations involved in skin cancer progression, response to therapy, and other clinical outcomes and 2) We are developing and implementing genome-wide genetic risk prediction assessments for skin cancer into clinical use and studying the impact of this information on patient care.
-
Peter Sarnow
Burt and Marion Avery Professor of Immunology
Current Research and Scholarly InterestsOur laboratory studies virus-host interactions with an emphasis microRNA-mediated gene regulation and on translational control. The mechanism by which a liver-specific microRNA regulates hepatitis C virus genome replication is under intense scrutiny. In addition, the mechanism of internal ribosome entry in certain cellular and viral mRNAs and its biological role in growth and development is being investigated.
-
Clea Sarnquist, DrPH, MPH
Clinical Professor, Pediatrics - Infectious Diseases
Clinical Professor (By courtesy), Epidemiology and Population HealthBioDr. Sarnquist focuses on applied teaching and research on the development, implementation and evaluation of interventions to decrease gender-based violence, improve mental health, and prevent HIV infection, especially among adolescents and children. She is particularly interested in rights-based approaches that tackle the complex interplay of factors that lead to poor health for many children and families. All of her work is applied, with direct links health practice and policy, and usually performed in conjunction with non-governmental organization and government partners. She works both globally and in the U.S., with a focus on sub-Saharan Africa. She is also a medical educator, directing the scholarly concentrations program of the pediatric residency at Stanford, co-directing the global health concentration for residents, and teaching graduate and undergraduate courses in global health with a focus on children and women’s health.
-
Ansuman Satpathy, MD, PhD
Associate Professor of Pathology
Current Research and Scholarly InterestsOur lab works at the interface of immunology, cancer biology, and genomics to study cellular and molecular mechanisms of the immune response to cancer. In particular, we are leveraging high-throughput genomic technologies to understand the dynamics of the tumor-specific T cell response to cancer antigens and immunotherapies (checkpoint blockade, CAR-T cells, and others). We are also interested in understanding the impact of immuno-editing on the heterogeneity and clonal evolution of cancer.
-
Elizabeth Sattely
Associate Professor of Chemical Engineering
BioPlants have an extraordinary capacity to harvest atmospheric CO2 and sunlight for the production of energy-rich biopolymers, clinically used drugs, and other biologically active small molecules. The metabolic pathways that produce these compounds are key to developing sustainable biofuel feedstocks, protecting crops from pathogens, and discovering new natural-product based therapeutics for human disease. These applications motivate us to find new ways to elucidate and engineer plant metabolism. We use a multidisciplinary approach combining chemistry, enzymology, genetics, and metabolomics to tackle problems that include new methods for delignification of lignocellulosic biomass and the engineering of plant antibiotic biosynthesis.
-
Nazish Sayed MD, PhD
Associate Professor (Research) of Surgery (Vascular Surgery)
Current Research and Scholarly InterestsThe Sayed Laboratory is focused on the development of novel technologies that drive innovation in regenerative medicine, disease modeling, and drug testing in vascular biology. The lab conducts translational research in vascular biology and aims to understand the role of the vasculature in the development of cardiac diseases, including those due to inherited genetic variants or environmental insults such as type 2 diabetes or hypertension. The lab employs the human induced pluripotent stem cell (iPSC) technology to generate patient-specific vascular cells (endothelial and vascular smooth muscle cells) as an alternative to animal models providing a human tissue surrogate for research that is scalable and sustainable. By employing this unique platform, the lab also investigates the role of chemotherapeutic agents (anti-cancer drugs) on the vasculature. Dr. Sayed’s lab has also established an endothelial regeneration program, where they leverage the innate immune system to regenerate endothelial cells from human fibroblasts.
Work from the lab has led to seminal discoveries in the areas of 1) Nitric oxide (NO) biology, (2) vascular biology, (3) stem cell biology, (4) cardiovascular disease modeling (5) cardio-oncology. -
Alan F. Schatzberg
Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsBiological bases of depressive disorders;, glucocorticoid/dopamine interactions in delusional depression;, pharmacologic treatment of depressive disorders.
-
Londa Schiebinger
John L. Hinds Professor of the History of Science
BioLonda Schiebinger is the John L. Hinds Professor of History of Science in the History Department at Stanford University and Director of the EU/US Gendered Innovations in Science, Health & Medicine, Engineering, and Environment Project. From 2004-2010, Schiebinger served as the Director of Stanford's Clayman Institute for Gender Research. She is a member of the American Academy of Arts and Sciences.
Professor Schiebinger received her Ph.D. from Harvard University in 1984 and is a leading international authority on gender in science and technology. Over the past thirty years, Schiebinger's work has been devoted to teasing apart three analytically distinct but interlocking pieces of the gender and science puzzle: the history of women's participation in science; gender in the structure of scientific institutions; and the gendering of human knowledge.
Londa Schiebinger presented the keynote address and wrote the conceptual background paper for the United Nations' Expert Group Meeting on Gender, Science, and Technology, September 2010 in Paris. She presented the findings at the United Nations in New York, February 2011 with an update spring 2014. In 2022, she prepared the background paper for the United Nations 67th session of the Commission on the Status of Women’s priority theme, Innovation and Technological Change, and Education in the Digital Age for Achieving Gender Equality and The Empowerment of all Women and Girls. Since 2023, Gendered Innovations has been a member of the UNFPA Equity 2030 Alliance.
In 2011-2014, Schiebinger entered into major collaborations with the European Commission and the U.S. National Science Foundation to promote Gendered Innovations in Science, Health & Medicine, Engineering, and Environment. This project draws experts from across the U.S., Europe, Canada, and Asia, and was presented at the European Parliament, July 2013 as Gendered Innovations: How Gender Analysis Contributes to Research. In 2018-2020, Schiebinger directed the European Commission Expert Group to produce Gendered Innovations 2: How Inclusive Analysis Contributes to Research and Innovation. Institutes for Gendered Innovations research opened in Soeul, South Korea, in 2015 and in Tokyo, Japan, in 2022.
Schiebinger’s work has been featured in Science: A Framework for Sex, Gender, and Diversity Analysis in Research: Funding Agencies Have Ample Room to Improve Their Policies (2022); Nature: Sex and Gender Analysis Improves Science and Engineering (2019); Nature: Design AI so that it's Fair (2018); Nature: Accounting for Sex and Gender Makes for Better Science (2020).
Her work in the eighteenth century investigates the circulation of knowledge in the Atlantic World. Her Secret Cures of Slaves: People, Plants, and Medicine in the Eighteenth-Century Atlantic World reconceptualizes research in four areas: first and foremost knowledge of African contributions to early modern science; the historiography of race in science; the history of human experimentation; and the role of science in the eighteenth-century Atlantic world. Her prize-winning Plants and Empire: Colonial Bioprospecting in the Atlantic World investigates women's indigenous knowledge of abortifacients and why this knowledge did not travel.
Londa Schiebinger has been the recipient of numerous prizes and awards, including the prestigious Alexander von Humboldt Research Prize and John Simon Guggenheim Fellowship. She was awarded an honorary doctorate from the Vrije Universiteit Brussel, Belgium (2013), the Faculty of Science, Lund University, Sweden (2017), and the University of Valencia, Spain (2018); the Berlin Falling Walls Breakthrough Winner in Science & Innovation Management (2022). Her work has been translated into numerous languages. In 2022/23, she served as an advisor to the Berlin University Alliance.
